Background Hepatocellular carcinoma (HCC) is a common abdominal cancer with poor
survival outcomes. Although there is growing evidence that N7-methylguanosine (m7G) is …

Purpose: The purpose of this study was to construct a novel risk scoring model with
prognostic value that could elucidate tumor immune microenvironment of hepatocellular …

Objective: The purpose of this study was to establish an N6-methylandenosine (m6A)-
related long non-coding RNA (lncRNA) signature to predict the prognosis of hepatocellular …

Accumulating studies have demonstrated critical roles of N6-methyladenosine (m6A)
modification and long noncoding RNAs (lncRNAs) in the biological processes leading to …

Background N6-methyladenosine (m6A)-mediated ribonucleic acid (RNA) methylation is
considered to be the most significant and abundant epigenetic modification in eukaryotic …

N7-Methylguanosine (m7G) modifications are a common type of posttranscriptional RNA
modifications. Its function in the tumor microenvironment (TME) has garnered widespread …

RNA modification of m6A/m5C/m1A contributes to the occurrence and development of
cancer. Consequently, this study aimed to investigate the functions of m6A/m5C/m1A …

Hepatocellular carcinoma (HCC), one of the most common tumors worldwide, has the fifth
highest mortality rate, which is increasing every year. At present, many studies have …

Hepatocellular carcinoma (HCC) is a common malignancy with higher mortality, and means
are urgently needed to improve the prognosis. T cell exclusion (TCE) plays a pivotal role in …

N7-Methylguanosine (m7G) modification holds significant importance in regulating
posttranscriptional gene expression in epigenetics. Long non-coding RNAs (lncRNAs) have …